Clinical Trials Logo

Dyslexia clinical trials

View clinical trials related to Dyslexia.

Filter by:

NCT ID: NCT04384718 Not yet recruiting - Clinical trials for Developmental Dyslexia

Assessing the Generalizability of the Tachidino Protocol to Different Clinical Contexts

Start date: June 2020
Phase:
Study type: Observational

The study aims to document the effectiveness and acceptability of the intervention system for specific reading and writing disorders, in use at Scientific Institute (IRCCS) Medea, as applied and adapted to a different clinical context and socio-demographic situation. To this purpose, two groups of children will be recruited and treated in two different contexts, and treatment outcomes will be compared. The first one is the centre where the Tachidino platform has been developed and validated, the second one is a different centre, in a different geographical region where lower digital alphabetization may be a disadvantaging factor, but lower population density and the presence of fewer centres for assessment and intervention for learning disorders make remotely monitored protocols even more valuable.

NCT ID: NCT04382482 Completed - Clinical trials for Developmental Dyslexia

Remotely Controlled Intervention for Developmental Reading and Spelling Disorders Through the Tachidino Platform

Start date: January 20, 2018
Phase:
Study type: Observational

The study aims to document the effects of the intervention system for specific reading and spelling disorders, currently in use at Scientific Institute (IRCCS) Medea as an innovative intervention model in e-health mode. The model constitutes the application of research data collected in more than fifteen years research on the causes of dyslexia and rehabilitation techniques, combined with the most advanced technologies for remotely-controlled clinical management and therapy monitoring through adaptive, self-updating algorithms. A single group of about 80 children will be observed and their performance on reading, spelling and metaphonological tests at pre-test, post-test and follow-up (after 6 months) will be recorded in order to assess improvement (and, consequently, treatment effectiveness) and its stability. The improvements obtained in four weeks treatment will subsequently be compared with those obtained with outpatient intervention programmes of the same duration and intensity.

NCT ID: NCT04323488 Enrolling by invitation - Clinical trials for Dyslexia, Developmental

Neural Mechanisms of Successful Intervention in Children With Dyslexia

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Dyslexia, an impairment in accurate or fluent word recognition, is the most common learning disability affecting roughly ten percent of children. This proposal capitalizes on cutting edge neuroimaging methods, in combination with reading education programs, to generate a new understanding of how successful reading education shapes the development of the brain circuits that support skilled reading. A deeper understanding of the mechanisms of successful remediation of dyslexia, and individual differences in learning, will pave the way for personalized approaches to dyslexia treatment.

NCT ID: NCT04287530 Recruiting - Clinical trials for Dyslexia, Developmental

Poly-unsaturated Fatty Acids and Developmental Dyslexia

Start date: May 2, 2020
Phase: N/A
Study type: Interventional

Poly-unsaturated fatty acids (PUFAs) represent a component of lipids that covers a relevant role in human diet and biological functions such as provision of energy, functionality of cell membranes and tissue metabolism. Fatty acids carbon chains can be saturated (with no presence of double bonds) or unsaturated (with one or more double bonds). PUFAs fall into the unsaturated group, and they can be divided into two classes: omega-3 (n-3) and omega-6 (n-6) fatty acids (FAs). PUFAs are relevant components of cellular membranes, phospholipids, and precursors of eicosanoids, which influence neuronal development and functioning, docosahexaenoic acid (DHA) and arachidonic acid (AA) in fact are involved in cell growth, neural signaling, and gene expression. The main natural dietary source for Eicosapentaenoic acid (EPA) and DHA is fish oil. It has also been shown how the Magnocellular system, which includes the retinal ganglion cells, the lateral geniculate nucleus (for the visual system, while the medial geniculate nucleus would be involved for the auditory system) of the thalamus, the posterior parietal cortex, various areas visual of the cortex and part of the cerebellum, is sensitive to the contribution of fatty acids through nutrition. A deficit related to the Magnocellular system, specialized in the processing of stimuli with high temporal frequencies and low spatial frequencies, in both the visual and auditory modalities, has been proposed as one of the causes of Developmental Dyslexia (DD). According to this hypothesis, an alteration at the magnocellular level would affect reading by hampering temporal processing of the visual signal and would reduce the quality of the phonological representations due to imperfect acoustic analysis of the incoming phonemes. It is therefore possible to hypothesize that supplementation of PUFA in dyslexic children would improve the functions of the M-system and thus create better conditions to the remediation of reading difficulties, especially through remediation programs specifically tapping visual attention and rapid processing of visual stimuli. The remediation program currently used at Scientific Institute (IRCCS) Medea, "Tachidino", based on tachistoscopic, hemisphere-specific stimulation and on training of selective visual-spatial attention, has exactly these characteristics. Hence, the present study aims to test the efficacy of PUFA supplementation before and during treatment with Tachidino.

NCT ID: NCT04277351 Completed - Dyslexia Clinical Trials

Role of Auditory Cortical Oscillations in Speech Processing and Dyslexia

Start date: September 1, 2016
Phase: N/A
Study type: Interventional

This study aims at investigating the role of low-gamma activity in phonemic encoding and its implication in dyslexia. Indeed, a phonological deficit, i.e. a difficulty in perceiving the sounds of speech, is strongly suspected in dyslexia but has never been conclusively associated with a specific underlying mechanism. The study employs transcranial alternating current stimulation in adults with and without dyslexia to exploit the effect of the stimulation on phonemic processing and neural activity measured with electroencephalography. In doing so, it would be possible to establishing a causal link between gamma oscillations and the phonological deficit in dyslexia.

NCT ID: NCT04250701 Completed - Clinical trials for Intellectual Disability

Postural Control, Grip Strength and Body Posture in Children With Intellectual Disability and Dyslexia

Start date: February 15, 2017
Phase:
Study type: Observational

This study investigates physical changes in children with Dyslexia and Intellectual Disability. Participants divided into three groups and Body Posture, Postural Control and Hand Grip Strengths was evaluated.

NCT ID: NCT04244578 Completed - Dyslexia Clinical Trials

Transcranial Direct Current Stimulation in the Treatment of Dyslexia.

Start date: May 1, 2016
Phase: N/A
Study type: Interventional

The present study grounds on the absence of evidence-based treatment in individuals with dyslexia. At this topic, the present study will explore the potential effect of transcranial direct current stimulation (tDCS) over parieto-occipital brain regions, cerebral areas usually disrupted in individuals with dyslexia. tDCS will be administered without concomitantly training. Therefore, the investigators hypothesized that active tDCS over parieto-occipital areas will enhance reading skills in children and adolescents with dyslexia. On the contrary, sham tDCS (placebo) over parieto-occipital areas will not have significant effect on reading. Further, both active and sham tDCS will be safe and well-tolerated.

NCT ID: NCT04235465 Completed - Clinical trials for Gait Disorders, Neurologic

Dynamic Gait Index in Children With Dyslexia

Start date: April 2, 2018
Phase:
Study type: Observational

The aim of the present study is to investigate reliability in dyslexic children and compare it with healthy peers.

NCT ID: NCT04157829 Completed - Dyslexia Clinical Trials

Evaluation of the Performance and Safety of a Medical Device Developed to Improve the Reading of Dyslexic Patients

DysLight
Start date: December 18, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy and safety of a new medical device on the improvement of reading skills of dyslexic patients.

NCT ID: NCT04122820 Recruiting - Clinical trials for Developmental Coordination Disorder

Ambulatory Screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD).

TDys
Start date: October 16, 2019
Phase: N/A
Study type: Interventional

To evaluate, in primary care, the sensitivity of Heterophory-Vertical-Labile (HV-Labile) in ambulatory screening for Specific Learning Disabilities (SLD) and Developmental Coordination Disorder (DCD). in children aged 8 to 12 years.